SEC Form 4 · accession 0001144204-18-030785
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James G. Marken
Officer — SVP Ops & Prod Dev
Period of report
May 22, 2018
Accepted (ET)
May 24, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2018 | F | 253 | $61.88 | D | 69,080 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of restricted stock, which was previously reported.